Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 7, 2009BloodOpen Access

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

View Full Paper
Ask AI
Bookmark
Share

Authors

Omar Abdel‐WahabOmar Abdel‐WahabBrigham and Women's HospitalAMAnn MullallyVA Palo Alto Health Care SystemCHCyrus V. HedvatIcahn School of Medicine at Mount Sinai

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abdel‐Wahab et al. (2009) studied this question.

synapsesocial.com/papers/6a036697f32c10a08381eacehttps://doi.org/10.1182/blood-2009-03-210039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.1996 · 5,687 citations
  2. 2Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC4122004 · 662 citations
  3. 3A Prospective Randomized Study Comparing Rituximab and Dexamethasone Vs Dexamethasone Alone in ITP: Results of Final Analysis and Long Term Follow up2008 · 26 citations
  4. 4A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders2005 · 3,497 citations
  5. 5A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes2003 · 61 citations